Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVERT: Toprol-XL in Asymptomatic Heart Failure
NCT00038077Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2001
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of s-metoprolol in left ventricular systolic dysfunction (LVSD), sponsored by AstraZeneca. Primary endpoint: Left Ventricular End-Systolic Volume Index at 12 months. Started Aug 2001; status: completed.
02
Drugs
s-metoprolol
03
Conditions
left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on NCT00038077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038077.